Muhammad Ali Selected Research

2- (6- (2,5- dimethoxyphenyl)- 4- oxo- 2- thioxo- 3,4- dihydropyrimidin- 1(2H)- yl)acetamide

12/2016

Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muhammad Ali Research Topics

Disease

38	Neoplasms (Cancer) 05/2022 - 01/2009
23	Infections 04/2022 - 01/2011
10	Inflammation (Inflammations) 01/2022 - 03/2009
8	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2016
7	Chronic Kidney Failure (Chronic Renal Failure) 08/2021 - 01/2018
7	Body Weight (Weight, Body) 04/2021 - 01/2014
7	Hypoxia (Hypoxemia) 10/2019 - 04/2015
6	Wounds and Injuries (Trauma) 02/2022 - 07/2003
6	COVID-19 01/2022 - 01/2020
6	Pain (Aches) 10/2021 - 04/2009
6	Diabetes Mellitus 01/2021 - 05/2015
5	Hypertension (High Blood Pressure) 01/2021 - 04/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2014
5	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2011
5	Fibrosis (Cirrhosis) 02/2018 - 03/2011
4	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 04/2009
4	Myocardial Infarction 05/2022 - 04/2012
4	Stroke (Strokes) 05/2022 - 01/2018
4	Hemorrhage 03/2022 - 05/2004
4	Edema (Dropsy) 02/2022 - 04/2009
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 04/2012
4	Obesity 01/2021 - 10/2017
4	Multiple Sclerosis 10/2019 - 05/2015
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2019 - 05/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 12/2022 - 01/2018
3	Epilepsy (Aura) 09/2022 - 03/2016
3	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2009
3	Carcinogenesis 01/2022 - 01/2016
3	Cataract (Cataracts) 01/2022 - 01/2016
3	Cerebral Hemorrhage 11/2021 - 01/2021
3	Burns 08/2021 - 01/2016
3	Chronic Hepatitis C 05/2021 - 05/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2021 - 01/2018
3	Brain Diseases (Brain Disorder) 01/2020 - 06/2015
3	Bronchiolitis Obliterans Syndrome 01/2018 - 08/2015
3	Non-alcoholic Fatty Liver Disease 01/2017 - 12/2015
3	Ischemia 09/2016 - 06/2015
2	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2019
2	Thrombosis (Thrombus) 05/2022 - 06/2020
2	Liver Neoplasms (Liver Cancer) 04/2022 - 12/2021
2	Glioma (Gliomas) 01/2022 - 12/2016
2	Amyloidosis 01/2022 - 01/2019
2	Disease Progression 10/2021 - 09/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 07/2018
2	Hypertriglyceridemia 01/2021 - 12/2017
2	Dyslipidemias (Dyslipidemia) 01/2021 - 10/2017
2	Male Infertility (Male Sterility) 01/2021 - 01/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 09/2016

Drug/Important Bio-Agent (IBA)

16	EnzymesIBA 01/2022 - 02/2005
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2009
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
12	Pharmaceutical PreparationsIBA 05/2022 - 05/2012
8	Biological ProductsIBA 04/2022 - 03/2009
8	AntioxidantsIBA 04/2022 - 09/2017
8	Peroxidase (Myeloperoxidase)IBA 01/2022 - 05/2015
6	Antiviral Agents (Antivirals)IBA 11/2021 - 03/2015
5	VaccinesIBA 01/2022 - 01/2011
5	PhytochemicalsIBA 10/2021 - 04/2012
4	Contrast MediaIBA 01/2022 - 07/2003
4	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2011
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 08/2013
4	Saline SolutionIBA 09/2019 - 01/2014
4	InterferonsIBA 05/2014 - 01/2011
3	Peptides (Polypeptides)IBA 06/2022 - 11/2021
3	CurcuminIBA 02/2022 - 09/2019
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2019
3	4-aminobenzhydrazideIBA 01/2022 - 02/2019
3	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 01/2011
3	LipidsIBA 01/2021 - 02/2018
3	Caspase 3 (Caspase-3)IBA 01/2020 - 08/2013
3	Messenger RNA (mRNA)IBA 02/2018 - 01/2009
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2018 - 01/2016
3	Therapeutic UsesIBA 01/2018 - 01/2013
3	SolventsIBA 05/2017 - 06/2015
3	Adenosine Triphosphate (ATP)IBA 12/2015 - 01/2011
3	isoalantolactoneIBA 10/2013 - 01/2013
2	EmulsionsIBA 06/2022 - 07/2021
2	AlginatesIBA 02/2022 - 08/2021
2	ChitosanIBA 02/2022 - 08/2021
2	Pentetic Acid (DTPA)FDA LinkGeneric 01/2022 - 05/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2015
2	PolyphenolsIBA 01/2022 - 01/2019
2	Indicators and Reagents (Reagents)IBA 11/2021 - 06/2021
2	FlavonoidsIBA 10/2021 - 04/2018
2	Analgesics (Analgesic Drugs)IBA 10/2021 - 04/2009
2	NivolumabIBA 10/2021 - 01/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2021 - 04/2012
2	SofosbuvirIBA 05/2021 - 09/2019
2	Neuroprotective AgentsIBA 05/2021 - 11/2015
2	CholesterolIBA 01/2021 - 08/2011

Therapy/Procedure

31	Therapeutics 12/2022 - 12/2002
10	Hematopoietic Stem Cell Transplantation 01/2022 - 10/2015
8	Drug Therapy (Chemotherapy) 01/2021 - 03/2010
5	Radiotherapy 12/2022 - 03/2010
5	Renal Dialysis (Hemodialysis) 08/2021 - 09/2019
4	Immunotherapy 01/2022 - 12/2016
4	Stem Cell Transplantation 01/2021 - 08/2015
4	Ligation 10/2018 - 04/2015
3	Transplantation 01/2022 - 10/2015